Major Institutional Investors Reveal Significant Portfolio Shifts Across Multiple Equities

BlueArc, a 10% owner of PBLSX, bought 2,446,183 shares on 10-24-2025 for an estimated $24,999,990, raising their stake to 4,933,746 shares (about a 98.3% increase).
Corient Private Wealth LP opened a new position in Progyny (PGNY) by acquiring 109,939 shares valued at approximately $3.17 million in the second quarter; this comes amid broad institutional activity in PGNY, including BlackRock taking a new stake in the quarter valued around $334.4 million and additional increases by State Street, Fort Washington, Wellington, and Ameriprise.
Corient also opened a new Hexcel (HXL) position in Q2, purchasing 32,578 shares valued at about $3.26 million; Hexcel drew sizable bets from others, notably BlackRock taking a new position in Q2 valued at roughly $1.42 billion, and AllianceBernstein increasing holdings to about 2,178,259 shares (~$123.05 million).
Corient purchased 145,067 shares of First Advantage Co. (FA) in the second quarter, valued at about $2.62 million; the report also notes executive activity with Director James Lindsey Clark selling 4,921 shares on June 8 under a Rule 10b5-1 plan.
Corient boosted exposure to Associated Banc-Corp (ASB) by purchasing 86,500 shares in the second quarter, valued at roughly $2.66 million; the piece also highlights that institutional ownership in ASB is high (about 82.98%), underscoring broad professional investor participation.
Corient Private Wealth LP is making a broad push into new stocks and expanding existing positions across mid-cap equities. The private wealth manager opened fresh stakes in Progyny (PGNY) and Hexcel (HXL) during the second quarter while also adding to holdings in First Advantage Co. (FA) and Associated Banc-Corp (ASB), signaling active portfolio rebalancing among top institutional investors watchlistnews.
The moves come as other major funds are also reshuffling portfolios across the same names. BlueArc, already a 10% owner, bought 2.4 million shares of PBLSX for nearly $25 million on October 24, 2025, nearly doubling its stake quiverquant. The activity reflects a broad institutional trend favoring fresh or expanded exposure in quality equities watchlistnews.
Corient opened a new Progyny stake by purchasing 109,939 shares worth $3.17 million in Q2. The move taps into a wave of big-money interest. BlackRock took a fresh Progyny position valued at $334.4 million that same quarter watchlistnews. Other major funds — State Street, Fort Washington, Wellington, and Ameriprise — also increased their holdings, reflecting broad enthusiasm around the fertility services company watchlistnews.
Corient purchased 32,578 Hexcel shares valued at $3.26 million in Q2, staking out a position in the advanced materials maker. The timing aligns with a flood of institutional capital into the stock. BlackRock opened a new position worth roughly $1.42 billion in the same quarter watchlistnews. AllianceBernstein also significantly increased holdings to about 2.2 million shares, worth $123 million watchlistnews.
BlueArc, which already owned 10% of PBLSX, aggressively expanded its position by purchasing 2.4 million shares for an estimated $25 million on October 24, 2025 quiverquant. The deal increased BlueArc's total stake to 4.9 million shares — a 98% jump quiverquant. The insider move signals strong conviction in the company's prospects.
Corient also deployed capital into First Advantage and Associated Banc-Corp in Q2. The firm bought 145,067 shares of First Advantage worth $2.62 million watchlistnews. For Associated Banc-Corp, Corient purchased 86,500 shares valued at $2.66 million watchlistnews. Both stocks are drawing broad institutional interest, with ASB boasting 83% institutional ownership watchlistnews.
Publishers
32
Articles
31
Reach
63